Technology News and Research

RSS

GeoVax Labs announces financial results and operational update for the third quarter of 2009

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2009 financial results and provided an operational update.

6 Nov 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus.

6 Nov 2009

GTC Biotherapeutics announces financial results for third quarter 2009

GTC Biotherapeutics, Inc.’s total net loss for the third quarter ended September 27, 2009 was $5.1 million, or $0.48 per share, compared with $6.1 million, or $0.59 per share, in the third quarter of 2008. The total net loss for the first nine months of 2009 was $26.2 million, or $2.51 per share, compared to $16.5 million, or $1.71 per share, for the first nine months of 2008.

6 Nov 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the latest recipient of the End Duchenne Grant Award Program.

6 Nov 2009

KFHP/H and their subsidiaries report total operating revenue of $10.5 billion for the quarter ended September 30, 2009

Kaiser Foundation Health Plan, Inc., Kaiser Foundation Hospitals (KFHP/H), and their subsidiaries reported today a combined total operating revenue of $10.5 billion for the quarter ended September 30, 2009, compared to $10.2 billion in the third quarter of last year.

6 Nov 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

6 Nov 2009

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

Fifty-five percent of the adult population in the Greater Washington, DC region say they will not get the H1N1 flu vaccine, according to a new poll commissioned by the Greater Washington Board of Trade.

6 Nov 2009

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

LifePoint Hospitals, Inc. today announced results for the third quarter and nine months ended September 30, 2009.

6 Nov 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 first quarter, ended September 30, 2009.

6 Nov 2009

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Are you a female athlete - or just someone who likes challenging workouts -- who also wants to get pregnant? It may make sense to ease off a bit as you try to get pregnant. New research from the Norwegian University of Science and Technology (NTNU) shows that the body may not have enough energy to support both hard workouts and getting pregnant.

6 Nov 2009

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.

6 Nov 2009

People pay more for products that carry detailed nutritional information than for light items

People would be willing to pay more for products that carry detailed nutritional information than for the so-called light items. Thus it has been confirmed by researchers from the University of Santiago de Compostela (USC) and the Centre for Agro-Food Research and Technology of Aragón (CITA) in a new study on the nutritional labelling of breakfast biscuits.

6 Nov 2009

NYUCN incorporates Epocrates software into its nursing program curriculum

Epocrates, Inc., developer of popular clinical reference and decision support tools, announced today that New York University College of Nursing (NYUCN) will provide its graduate students with the company’s mobile software. Building upon its history of nursing excellence, NYUCN has incorporated Epocrates® software and the use of mobile devices into its comprehensive graduate curriculum.

6 Nov 2009

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Results of a long QT syndrome (LQTS) study published in the current issue of Circulation play an important role in understanding genetic testing's role in diagnosing disease, according to the senior author, Michael Ackerman, M.D., Ph.D. A pediatric cardiologist at Mayo Clinic, Dr. Ackerman directs Mayo's Long QT Syndrome Clinic and is the director of the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory.

6 Nov 2009

Sectra and Emitac Healthcare sign distribution agreement

The Swedish IT and medical-technology company Sectra (STO:SECTB) has signed a distribution agreement with Emitac Healthcare, a leading medical technology company in the United Arab Emirates and Qatar.

6 Nov 2009

Eggs sensitivity and flu shot: Doctors' dilemma

"My three year old had a skin breakout we think was due to eggs - is it safe to do a flu shot?" It's a question being asked to every doctor who takes care of kids during flu season. "On the one hand we are concerned about the devastating effects of the new strain of flu, and on the other we aren't sure if a history of eggs sensitivity is enough to hold the shot or spray," said Bobby Q. Lanier, M.D., clinical professor of pediatrics at the University of North Texas HSC in Fort Worth, Texas, and executive medical director of the American College of Allergy, Asthma and Immunology (ACAAI).

6 Nov 2009

Smith & Nephew reports third quarter 2009 financial results

Smith & Nephew Q3 Results - continued strong profit performance 6 November 2009 Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, announces its results for the third quarter ended 26 September 2009.

6 Nov 2009

Broad Institute purchases 30 additional Genome Analyzers from Illumina

Illumina, Inc. today announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.

From Illumina, Inc. 6 Nov 2009

Patent awarded to US Spine for its method of facet fixation using the Facet Gun and Facet Bolt

US Spine® has announced that it has been awarded patent number 7,608,094, the second in a series of patents for facet fixation. This patent provides protection to the company for its method of facet fixation using the Facet Gun™ and Facet Bolt®. Additional patents covering other devices and methods are expected to follow.

6 Nov 2009

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Results of the FDA pivotal clinical trial for the LightTouch™ Non-invasive Cervical Cancer Detection Device conducted by Guided Therapeutics, Inc. (GT), indicated that the current system for diagnosing cervical disease missed the same amount of disease as a landmark study carried out by the National Cancer Institute (NCI).

6 Nov 2009

Technology News and Research

GeoVax Labs announces financial results and operational update for the third quarter of 2009

Calbiotech awarded a SBIR contract to develop analyte specific reagents for the diagnosis of Dengue virus

GTC Biotherapeutics announces financial results for third quarter 2009

PPMD awards $75,000 grant to University of California professor for Duchenne muscular dystrophy research

KFHP/H and their subsidiaries report total operating revenue of $10.5 billion for the quarter ended September 30, 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

55% of adult population in Greater Washington, DC say they will not get H1N1 flu vaccine, reveals poll results

LifePoint Hospitals reports financial results for the third quarter ended September 30, 2009

Bioniche Life Sciences announces financial results for its Fiscal 2010 first-quarter

Women may not have enough energy to support both hard workouts and getting pregnant: Study

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

People pay more for products that carry detailed nutritional information than for light items

NYUCN incorporates Epocrates software into its nursing program curriculum

Long QT syndrome study reveals importance of genetic testing's role in diagnosing disease

Sectra and Emitac Healthcare sign distribution agreement

Eggs sensitivity and flu shot: Doctors' dilemma

Smith & Nephew reports third quarter 2009 financial results

Broad Institute purchases 30 additional Genome Analyzers from Illumina

Patent awarded to US Spine for its method of facet fixation using the Facet Gun and Facet Bolt

Results of LightTouch Non-invasive Cervical Cancer Detection Device trial presented

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News